Release 4

This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU) in it's permanent home (it will always be available at this URL). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.4.1.234 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group Maturity Level: 1Draft Use Context: Any

This is a value set defined by the FHIR project.

Summary

Defining URL:http://hl7.org/fhir/ValueSet/vaccine-code
Version:4.0.1
Name:VaccineAdministeredValueSet
Title:Vaccine Administered Value Set
Definition:

This identifies the vaccine substance administered - CVX codes.

Committee:Public Health and Emergency Response Work Group
OID:2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:

4.4.1.234.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17

 

4.4.1.234.2 Expansion

This expansion generated 01 Nov 2019

This value set contains 268 concepts

CodeSystemDisplay
143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7
54http://hl7.org/fhir/sid/cvxadenovirus, type 4
55http://hl7.org/fhir/sid/cvxadenovirus, type 7
82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation
24http://hl7.org/fhir/sid/cvxanthrax
181http://hl7.org/fhir/sid/cvxanthrax immune globulin
801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
19http://hl7.org/fhir/sid/cvxBCG
27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
173http://hl7.org/fhir/sid/cvxcholera, BivWC
174http://hl7.org/fhir/sid/cvxcholera, live attenuated
26http://hl7.org/fhir/sid/cvxcholera, unspecified formulation
172http://hl7.org/fhir/sid/cvxcholera, WC-rBS
29http://hl7.org/fhir/sid/cvxCMVIG
56http://hl7.org/fhir/sid/cvxdengue fever
12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
28http://hl7.org/fhir/sid/cvxDT (pediatric)
20http://hl7.org/fhir/sid/cvxDTaP
106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens
107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation
146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB
110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV
50http://hl7.org/fhir/sid/cvxDTaP-Hib
120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV
130http://hl7.org/fhir/sid/cvxDTaP-IPV
132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical
170http://hl7.org/fhir/sid/cvxDTAP/IPV/HIB - non-US
01http://hl7.org/fhir/sid/cvxDTP
22http://hl7.org/fhir/sid/cvxDTP-Hib
102http://hl7.org/fhir/sid/cvxDTP-Hib-Hep B
57http://hl7.org/fhir/sid/cvxhantavirus
30http://hl7.org/fhir/sid/cvxHBIG
52http://hl7.org/fhir/sid/cvxHep A, adult
154http://hl7.org/fhir/sid/cvxHep A, IG
169http://hl7.org/fhir/sid/cvxHep A, live attenuated
83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose
84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose
31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation
85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation
104http://hl7.org/fhir/sid/cvxHep A-Hep B
193http://hl7.org/fhir/sid/cvxHep A-Hep B, pediatric/adolescent
08http://hl7.org/fhir/sid/cvxHep B, adolescent or pediatric
42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant
43http://hl7.org/fhir/sid/cvxHep B, adult
44http://hl7.org/fhir/sid/cvxHep B, dialysis
45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation
58http://hl7.org/fhir/sid/cvxHep C
59http://hl7.org/fhir/sid/cvxHep E
189http://hl7.org/fhir/sid/cvxHepB-CpG
60http://hl7.org/fhir/sid/cvxherpes simplex 2
47http://hl7.org/fhir/sid/cvxHib (HbOC)
46http://hl7.org/fhir/sid/cvxHib (PRP-D)
49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)
48http://hl7.org/fhir/sid/cvxHib (PRP-T)
17http://hl7.org/fhir/sid/cvxHib, unspecified formulation
51http://hl7.org/fhir/sid/cvxHib-Hep B
61http://hl7.org/fhir/sid/cvxHIV
118http://hl7.org/fhir/sid/cvxHPV, bivalent
62http://hl7.org/fhir/sid/cvxHPV, quadrivalent
137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
165http://hl7.org/fhir/sid/cvxHPV9
86http://hl7.org/fhir/sid/cvxIG
14http://hl7.org/fhir/sid/cvxIG, unspecified formulation
87http://hl7.org/fhir/sid/cvxIGIV
160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013
151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203
135http://hl7.org/fhir/sid/cvxInfluenza, high dose seasonal
153http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free
171http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free, quadrivalent
186http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, quadrivalent, preservative
158http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent
150http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent, preservative free
161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free
111http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal
149http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal, quadrivalent
155http://hl7.org/fhir/sid/cvxinfluenza, recombinant, injectable, preservative free
185http://hl7.org/fhir/sid/cvxinfluenza, recombinant, quadrivalent,injectable, preservative free
141http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable
140http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable, preservative free
144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free
15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)
168http://hl7.org/fhir/sid/cvxinfluenza, trivalent, adjuvanted
88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation
16http://hl7.org/fhir/sid/cvxinfluenza, whole
10http://hl7.org/fhir/sid/cvxIPV
134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM
39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC
129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation
63http://hl7.org/fhir/sid/cvxJunin virus
64http://hl7.org/fhir/sid/cvxleishmaniasis
65http://hl7.org/fhir/sid/cvxleprosy
66http://hl7.org/fhir/sid/cvxLyme disease
04http://hl7.org/fhir/sid/cvxM/R
67http://hl7.org/fhir/sid/cvxmalaria
05http://hl7.org/fhir/sid/cvxmeasles
68http://hl7.org/fhir/sid/cvxmelanoma
191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide (non-US)
192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide (non-US)
108http://hl7.org/fhir/sid/cvxmeningococcal ACWY, unspecified formulation
163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV
162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant
164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified
103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate
148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP
147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation
136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O
114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P
32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4
167http://hl7.org/fhir/sid/cvxmeningococcal, unknown serogroups
03http://hl7.org/fhir/sid/cvxMMR
94http://hl7.org/fhir/sid/cvxMMRV
07http://hl7.org/fhir/sid/cvxmumps
127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09
128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations
125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal
126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free
02http://hl7.org/fhir/sid/cvxOPV
179http://hl7.org/fhir/sid/cvxOPV ,monovalent, unspecified
178http://hl7.org/fhir/sid/cvxOPV bivalent
182http://hl7.org/fhir/sid/cvxOPV, Unspecified
69http://hl7.org/fhir/sid/cvxparainfluenza-3
177http://hl7.org/fhir/sid/cvxPCV10
11http://hl7.org/fhir/sid/cvxpertussis
23http://hl7.org/fhir/sid/cvxplague
133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13
100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7
152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23
109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation
89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation
70http://hl7.org/fhir/sid/cvxQ fever
175http://hl7.org/fhir/sid/cvxRabies - IM Diploid cell culture
176http://hl7.org/fhir/sid/cvxRabies - IM fibroblast culture
40http://hl7.org/fhir/sid/cvxrabies, intradermal injection
18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection
90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation
72http://hl7.org/fhir/sid/cvxrheumatic fever
159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation
157http://hl7.org/fhir/sid/cvxRho(D) -IG IM
156http://hl7.org/fhir/sid/cvxRho(D)-IG
73http://hl7.org/fhir/sid/cvxRift Valley fever
34http://hl7.org/fhir/sid/cvxRIG
119http://hl7.org/fhir/sid/cvxrotavirus, monovalent
116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent
74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent
122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation
71http://hl7.org/fhir/sid/cvxRSV-IGIV
93http://hl7.org/fhir/sid/cvxRSV-MAb
145http://hl7.org/fhir/sid/cvxRSV-MAb (new)
06http://hl7.org/fhir/sid/cvxrubella
38http://hl7.org/fhir/sid/cvxrubella/mumps
76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate
138http://hl7.org/fhir/sid/cvxTd (adult)
09http://hl7.org/fhir/sid/cvxTd (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
113http://hl7.org/fhir/sid/cvxTd (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
115http://hl7.org/fhir/sid/cvxTdap
180http://hl7.org/fhir/sid/cvxtetanus immune globulin
35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
77http://hl7.org/fhir/sid/cvxtick-borne encephalitis
13http://hl7.org/fhir/sid/cvxTIG
98http://hl7.org/fhir/sid/cvxTST, unspecified formulation
95http://hl7.org/fhir/sid/cvxTST-OT tine test
96http://hl7.org/fhir/sid/cvxTST-PPD intradermal
97http://hl7.org/fhir/sid/cvxTST-PPD tine test
78http://hl7.org/fhir/sid/cvxtularemia vaccine
190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (TCV)
25http://hl7.org/fhir/sid/cvxtyphoid, oral
41http://hl7.org/fhir/sid/cvxtyphoid, parenteral
53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)
91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation
101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs
131http://hl7.org/fhir/sid/cvxtyphus, historical
75http://hl7.org/fhir/sid/cvxvaccinia (smallpox)
105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted
79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
21http://hl7.org/fhir/sid/cvxvaricella
81http://hl7.org/fhir/sid/cvxVEE, inactivated
80http://hl7.org/fhir/sid/cvxVEE, live
92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation
36http://hl7.org/fhir/sid/cvxVZIG
117http://hl7.org/fhir/sid/cvxVZIG (IND)
37http://hl7.org/fhir/sid/cvxyellow fever
183http://hl7.org/fhir/sid/cvxYellow fever vaccine - alt
184http://hl7.org/fhir/sid/cvxYellow fever, unspecified formulation
121http://hl7.org/fhir/sid/cvxzoster live
187http://hl7.org/fhir/sid/cvxzoster recombinant
188http://hl7.org/fhir/sid/cvxzoster, unspecified formulation
998http://hl7.org/fhir/sid/cvxno vaccine administered
99http://hl7.org/fhir/sid/cvxRESERVED - do not use
999http://hl7.org/fhir/sid/cvxunknown
AGRPALurn:oid:1.2.36.1.2001.1005.17Agrippal
AVAXMurn:oid:1.2.36.1.2001.1005.17Avaxim
BCGurn:oid:1.2.36.1.2001.1005.17BCG
CDTurn:oid:1.2.36.1.2001.1005.17CDT
CMXurn:oid:1.2.36.1.2001.1005.17COMVAX
DTPurn:oid:1.2.36.1.2001.1005.17Triple Antigen
DTPAurn:oid:1.2.36.1.2001.1005.17DTPa
ENGPurn:oid:1.2.36.1.2001.1005.17Engerix B
FLRIXurn:oid:1.2.36.1.2001.1005.17Fluarix
FLUVAXurn:oid:1.2.36.1.2001.1005.17Fluvax
FLVRNurn:oid:1.2.36.1.2001.1005.17Fluvirin
FVXJNRurn:oid:1.2.36.1.2001.1005.17Fluvax Junior
GNDIPurn:oid:1.2.36.1.2001.1005.17Diphtheria
GNFLUurn:oid:1.2.36.1.2001.1005.17Influenza
GNHEPurn:oid:1.2.36.1.2001.1005.17Hepatitis B
GNHIBurn:oid:1.2.36.1.2001.1005.17HIB
GNHPAurn:oid:1.2.36.1.2001.1005.17Hepatitis A
GNJENurn:oid:1.2.36.1.2001.1005.17Japanese Encephalitis
GNMEAurn:oid:1.2.36.1.2001.1005.17Measles
GNMENurn:oid:1.2.36.1.2001.1005.17Meningococcal C
GNMUMurn:oid:1.2.36.1.2001.1005.17Mumps
GNPNEurn:oid:1.2.36.1.2001.1005.17Pneumococcal
GNPOLurn:oid:1.2.36.1.2001.1005.17Polio
GNROXurn:oid:1.2.36.1.2001.1005.17Rotavirus
GNRUBurn:oid:1.2.36.1.2001.1005.17Rubella
GNTETurn:oid:1.2.36.1.2001.1005.17Tetanus
GNVARurn:oid:1.2.36.1.2001.1005.17Varicella
HATWNJurn:oid:1.2.36.1.2001.1005.17Twinrix Junior
HAVAQurn:oid:1.2.36.1.2001.1005.17Vaqta Paed/Adol
HAVJurn:oid:1.2.36.1.2001.1005.17Havrix Junior
HBOCurn:oid:1.2.36.1.2001.1005.17HibTITER
HBVurn:oid:1.2.36.1.2001.1005.17HBV
HBVPurn:oid:1.2.36.1.2001.1005.17HBVAX II
HBXurn:oid:1.2.36.1.2001.1005.17Hiberix
IFHXurn:oid:1.2.36.1.2001.1005.17Infanrix Hexa
IFIPurn:oid:1.2.36.1.2001.1005.17Infanrix-IPV
IFPAurn:oid:1.2.36.1.2001.1005.17Infanrix Penta
IFXurn:oid:1.2.36.1.2001.1005.17Infanrix
IFXBurn:oid:1.2.36.1.2001.1005.17InfanrixHepB
INFLUVurn:oid:1.2.36.1.2001.1005.17Influvac
IPVurn:oid:1.2.36.1.2001.1005.17IPOL
JEVAXurn:oid:1.2.36.1.2001.1005.17JE-VAX
MENJUGurn:oid:1.2.36.1.2001.1005.17Menjugate
MENTECurn:oid:1.2.36.1.2001.1005.17Meningitec
MENUMEurn:oid:1.2.36.1.2001.1005.17Menomune
MENVAXurn:oid:1.2.36.1.2001.1005.17Mencevax ACWY
MMRurn:oid:1.2.36.1.2001.1005.17MMR
MMRCSLurn:oid:1.2.36.1.2001.1005.17MMR II
MMRSKBurn:oid:1.2.36.1.2001.1005.17Priorix
MNTRXurn:oid:1.2.36.1.2001.1005.17Menitorix
NEISVCurn:oid:1.2.36.1.2001.1005.17NeisVac-C
OPVurn:oid:1.2.36.1.2001.1005.17Polio
Purn:oid:1.2.36.1.2001.1005.17Pertussis
PANVAXurn:oid:1.2.36.1.2001.1005.17Panvax
PDCLurn:oid:1.2.36.1.2001.1005.17Pediacel
PLCLurn:oid:1.2.36.1.2001.1005.17Poliacel
PNEUMOurn:oid:1.2.36.1.2001.1005.17Pneumovax
PRPDurn:oid:1.2.36.1.2001.1005.17ProHIBit
PROQADurn:oid:1.2.36.1.2001.1005.17ProQuad
PRPOMPurn:oid:1.2.36.1.2001.1005.17PedvaxHIB
PRPTurn:oid:1.2.36.1.2001.1005.17ActHIB
PRVNRurn:oid:1.2.36.1.2001.1005.17Prevenar 7
PRVTHurn:oid:1.2.36.1.2001.1005.17Prevenar 13
PRXTEXurn:oid:1.2.36.1.2001.1005.17Priorix-Tetra
QDCLurn:oid:1.2.36.1.2001.1005.17Quadracel
ROTRIXurn:oid:1.2.36.1.2001.1005.17Rotarix
ROTTEQurn:oid:1.2.36.1.2001.1005.17Rotateq
SYNFLXurn:oid:1.2.36.1.2001.1005.17Synflorix
TCLurn:oid:1.2.36.1.2001.1005.17Tripacel
VAXGRPurn:oid:1.2.36.1.2001.1005.17Vaxigrip
VGRJNRurn:oid:1.2.36.1.2001.1005.17Vaxigrip Junior
VLRIXurn:oid:1.2.36.1.2001.1005.17Varilrix
VRVAXurn:oid:1.2.36.1.2001.1005.17Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code